MedPage Today, March 28, 2018. If a doctor sells a cure to a disease, the FDA can warn them to stop, but the agency only has jurisdiction if research is involved. NCHR president explains that this loophole has existed for years and that it’s harming patients.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
At White House Meeting, Video Game Industry Denies Role in Gun Violence
WJLA, March 8, 2018. NCHR president explains to WJLA that violent video games can inspire violence, but access to guns is the biggest issue because the most harm is done when kids have access to weapons.
Read More »FDA Proposes Allowing Medical Device Makers to Summarize Malfunctions
Star Tribune, February 24, 2018. A Food and Drug Administration (FDA) proposal to let medical device makers summarize complications caused by medical devices instead of filing a report for each incident has kicked off a debate over safety. NCHR and patient and public health advocates say this would keep too many details secret.
Read More »FDA and Opioids: Too Much Regulation or Not Enough?
MedPage Today, January 31, 2018. The FDA is trying to find a streamlined approach to the opioid crisis. Dr. Zuckerman urged the FDA to include education on “abuse deterrent” within its Risk Evaluation and Mitigation Strategies since the term is often misinterpreted to mean the drug is less addictive.
Read More »Trump Targets Drug Prices, Right-to-Try in State of the Union
AJMC Newsroom, January 31, 2018. At the State of the Union, Trump vowed to bring down the high cost of prescription drugs and called on Congress to pass the Right to Try bill. This bill might end up doing more harm than good for patients.
Read More »